NIT
EPZM

NumerixS Investment Technologies’s Epizyme, Inc EPZM Stock Holding History

NumerixS Investment Technologies’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,794
Closed -$93K – 957
2020
Q2 		$93K Buy
+5,794
New +$101K 0.03% 606
2018
Q3 		– Sell
-1,000
Closed -$13K – 1420
2018
Q2 		$13K Buy
+1,000
New +$15.6K ﹤0.01% 1043
2018
Q1 		– Sell
-6,100
Closed -$77K – 1343
2017
Q4 		$77K Buy
6,100
+2,100
+53% +$30.5K 0.02% 772
2017
Q3 		$76K Sell
4,000
-300
-7% -$4.58K 0.02% 832
2017
Q2 		$65K Buy
+4,300
New +$65K 0.01% 921

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NumerixS Investment Technologies's EPZM Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Epizyme, Inc (EPZM) in Q3 2020, closing a stake of 5,794 shares — an estimated $93K sold.

NumerixS Investment Technologies first reported a position in EPZM in Q2 2017 and held it in 5 quarters. The position peaked at $93K in Q2 2020. 151 funds tracked by Wall St. Rank hold EPZM as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Epizyme, Inc position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 5,794 Epizyme, Inc shares in Q3 2020, an estimated $93K.
  • NumerixS Investment Technologies first reported a position in Epizyme, Inc in Q2 2017 and held it in 5 quarters.
  • NumerixS Investment Technologies's Epizyme, Inc position peaked at $93K in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.